首页> 外文期刊>In vivo. >AVATAR: Analysis for Visual Acuity Prediction After Eye Interventional Radiotherapy
【24h】

AVATAR: Analysis for Visual Acuity Prediction After Eye Interventional Radiotherapy

机译:头像:眼介性放射治疗后视力预测的分析

获取原文
           

摘要

Aim: The aim of this study was to detect clinical factors predictive of loss of visual acuity after treatment in order to develop a predictive model to help identify patients at risk of visual loss. Patients and Methods: This was a retrospective review of patients who underwent interventional radiotherapy (brachytherapy) with 106Ru plaque for primary uveal melanoma. A predictive nomogram for visual acuity loss at 3 years from treatment was developed. Results: A total of 152 patients were selected for the study. The actuarial probability of conservation of 20/40 vision or better was 0.74 at 1 year, 0.59 at 3 years, and 0.54 at 5 years after treatment. Factors positively correlated with loss of visual acuity included: age at start of treatment (p=0.004) and longitudinal basal diameter (p=0.057), while distance of the posterior margin of the tumor from the foveola was inversely correlated (p=0.0007). Conclusion: We identified risk factors affecting visual function and developed a predictive model and decision support tool (AVATAR nomogram).
机译:目的:本研究的目的是检测治疗后视力损失预测的临床因素,以便开发预测模型,以帮助识别视力损失风险的患者。患者及方法:这是对介入放疗(近距离放射治疗)的患者对原发性无过肺黑素瘤进行介入放疗(近距离放射治疗)的回顾性审查。开发了一种从治疗3年内为视力损失的预测性载体。结果:共选出152名患者进行研究。 5年后,守恒守恒的精算概率为0.74,3岁为0.59,治疗后5年为0.54。因素与视力的损失呈正相关:治疗开始时的年龄(p = 0.004)和纵向基础直径(p = 0.057),而肿瘤后缘与Foveola的距离相反(p = 0.0007) 。结论:我们确定了影响视觉功能的危险因素,并开发了一种预测模型和决策支持工具(化身Nom图)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号